{"hands_on_practices": [{"introduction": "A cornerstone of epidemiology is accurately measuring the occurrence of new disease cases. In studies of HIV, where individuals are enrolled and followed for varying lengths of time, the incidence density, or person-time rate, is the gold-standard measure. This exercise [@problem_id:4985228] will guide you through calculating HIV incidence from a hypothetical cohort study, giving you hands-on practice with the critical concepts of person-time, staggered entry, and censoring due to loss to follow-up. By also exploring a worst-case scenario for those lost, you will learn the importance of sensitivity analysis in assessing the robustness of your findings.", "problem": "A community-based cohort study of Human Immunodeficiency Virus (HIV) acquisition follows a dynamic population over calendar time, with staggered entry and right-censoring due to seroconversion, loss to follow-up, or administrative study end. The study runs from month $0$ to month $24$. For each individual below, the entry time, and either the exit time and reason or the seroconversion time, are recorded in months since study start. For those who seroconvert, follow-up stops at the seroconversion time. For those lost to follow-up, follow-up stops at their last observed visit. For those administratively censored, follow-up stops at month $24$.\n\nThe $12$ individuals are:\n- Person $1$: entry month $0$, exit month $24$, no seroconversion (administrative censoring).\n- Person $2$: entry month $0$, seroconversion at month $9$.\n- Person $3$: entry month $3$, lost to follow-up at month $15$, no documented seroconversion.\n- Person $4$: entry month $6$, exit month $24$, no seroconversion (administrative censoring).\n- Person $5$: entry month $6$, seroconversion at month $20$.\n- Person $6$: entry month $12$, exit month $24$, no seroconversion (administrative censoring).\n- Person $7$: entry month $0$, lost to follow-up at month $8$, no documented seroconversion.\n- Person $8$: entry month $10$, seroconversion at month $16$.\n- Person $9$: entry month $2$, exit month $24$, no seroconversion (administrative censoring).\n- Person $10$: entry month $14$, exit month $24$, no seroconversion (administrative censoring).\n- Person $11$: entry month $4$, lost to follow-up at month $7$, no documented seroconversion.\n- Person $12$: entry month $18$, exit month $24$, no seroconversion (administrative censoring).\n\nTasks:\n- (a) Using only the fundamental definition of incidence density in a dynamic cohort, compute the conventional incidence density of HIV seroconversion as events per $100$ person-years by summing individual person-time from entry to the earliest of seroconversion, loss, or study end, and summing observed seroconversions. Round your answer for this part to three significant figures and express it in events per $100$ person-years.\n- (b) To assess sensitivity to censoring, compute an upper-bound incidence density under the extreme assumption that each individual lost to follow-up actually seroconverted immediately after their last observed visit (thereby adding all losses to the event count without increasing follow-up time). Round your answer for this part to three significant figures and express it in events per $100$ person-years.\n- (c) Finally, compute the sensitivity ratio defined as the ratio of the upper-bound incidence density from part (b) to the conventional incidence density from part (a). Report this ratio as a unitless number. This ratio is the requested final answer.", "solution": "The problem requires the calculation of an HIV incidence density rate from cohort data, a subsequent sensitivity analysis, and finally, the ratio of the two rates. The problem is well-posed, scientifically grounded in standard epidemiological methods, and provides all necessary data for a unique solution.\n\nThe fundamental definition of incidence density ($ID$) in a dynamic cohort is the number of new cases (events) occurring during a period divided by the total person-time at risk during that period.\n$$ID = \\frac{\\text{Number of new cases}}{\\text{Total person-time at risk}}$$\nThe problem specifies the rate to be expressed in events per $100$ person-years, while the data are given in months. The conversion formula is:\n$$ID_{\\text{per 100 PY}} = \\frac{\\text{Number of events}}{\\text{Total person-months}} \\times \\frac{12 \\text{ months}}{1 \\text{ year}} \\times 100$$\n\n(a) Computation of the conventional incidence density ($ID_a$).\n\nFirst, we must calculate the total person-time at risk by summing the follow-up duration for each of the $12$ individuals. For each individual, the person-time is the duration from their entry month to the month of their exit event (seroconversion, loss to follow-up, or administrative censoring at month $24$). Let $t_i$ be the person-time contribution in months for person $i$.\n\nThe contributions are as follows:\n- Person $1$: Entry $0$, exit $24$ (administrative censoring). $t_1 = 24 - 0 = 24$ months.\n- Person $2$: Entry $0$, exit $9$ (seroconversion). $t_2 = 9 - 0 = 9$ months.\n- Person $3$: Entry $3$, exit $15$ (lost to follow-up). $t_3 = 15 - 3 = 12$ months.\n- Person $4$: Entry $6$, exit $24$ (administrative censoring). $t_4 = 24 - 6 = 18$ months.\n- Person $5$: Entry $6$, exit $20$ (seroconversion). $t_5 = 20 - 6 = 14$ months.\n- Person $6$: Entry $12$, exit $24$ (administrative censoring). $t_6 = 24 - 12 = 12$ months.\n- Person $7$: Entry $0$, exit $8$ (lost to follow-up). $t_7 = 8 - 0 = 8$ months.\n- Person $8$: Entry $10$, exit $16$ (seroconversion). $t_8 = 16 - 10 = 6$ months.\n- Person $9$: Entry $2$, exit $24$ (administrative censoring). $t_9 = 24 - 2 = 22$ months.\n- Person $10$: Entry $14$, exit $24$ (administrative censoring). $t_{10} = 24 - 14 = 10$ months.\n- Person $11$: Entry $4$, exit $7$ (lost to follow-up). $t_{11} = 7 - 4 = 3$ months.\n- Person $12$: Entry $18$, exit $24$ (administrative censoring). $t_{12} = 24 - 18 = 6$ months.\n\nThe total person-months at risk, $T_{PM,a}$, is the sum of these individual contributions:\n$$T_{PM,a} = 24 + 9 + 12 + 18 + 14 + 12 + 8 + 6 + 22 + 10 + 3 + 6 = 144 \\text{ person-months}$$\nNext, we count the number of observed seroconversion events, $E_a$. The individuals who seroconverted are Person $2$, Person $5$, and Person $8$.\n$$E_a = 3$$\nThe conventional incidence density, $ID_a$, is then:\n$$ID_a = \\frac{E_a}{T_{PM,a}} \\times 12 \\times 100 = \\frac{3}{144} \\times 12 \\times 100 = \\frac{1}{48} \\times 1200 = 25 \\text{ events per } 100 \\text{ person-years}$$\nRounding to three significant figures as requested gives $25.0$.\n\n(b) Computation of the upper-bound incidence density ($ID_b$).\n\nThis part requires a sensitivity analysis under the assumption that all individuals lost to follow-up are treated as if they seroconverted immediately after their last visit. The problem explicitly states this \"add[s] all losses to the event count without increasing follow-up time.\"\nTherefore, the total person-time at risk remains unchanged:\n$$T_{PM,b} = T_{PM,a} = 144 \\text{ person-months}$$\nThe number of events, $E_b$, is the sum of the documented seroconversions and the individuals lost to follow-up. The individuals lost to follow-up are Person $3$, Person $7$, and Person $11$.\n$$E_b = (\\text{seroconversions}) + (\\text{losses}) = 3 + 3 = 6$$\nThe upper-bound incidence density, $ID_b$, is:\n$$ID_b = \\frac{E_b}{T_{PM,b}} \\times 12 \\times 100 = \\frac{6}{144} \\times 12 \\times 100 = \\frac{1}{24} \\times 1200 = 50 \\text{ events per } 100 \\text{ person-years}$$\nRounding to three significant figures as requested gives $50.0$.\n\n(c) Computation of the sensitivity ratio.\n\nThe final requested answer is the sensitivity ratio, $R$, defined as the ratio of the upper-bound incidence density to the conventional incidence density.\n$$R = \\frac{ID_b}{ID_a}$$\nUsing the precise values is most accurate. The calculation can be simplified by noting that the person-time and conversion factors are identical in the numerator and denominator, canceling each other out.\n$$R = \\frac{\\frac{E_b}{T_{PM,b}} \\times 12 \\times 100}{\\frac{E_a}{T_{PM,a}} \\times 12 \\times 100} = \\frac{E_b}{E_a} \\quad (\\text{since } T_{PM,a} = T_{PM,b})$$\nSubstituting the event counts:\n$$R = \\frac{6}{3} = 2$$\nThe sensitivity ratio is a unitless value of $2$.", "answer": "$$\\boxed{2}$$", "id": "4985228"}, {"introduction": "While incidence rates tell us the frequency of new infections, the effective reproduction number, $R_t$, tells us whether an epidemic is growing or shrinking. Understanding how interventions impact $R_t$ is central to epidemic control. This practice [@problem_id:4985285] demonstrates how to quantify the population-level effect of Antiretroviral Therapy (ART), a cornerstone of HIV control. You will derive and apply a formula that combines the baseline epidemic potential ($R_0$) with ART coverage and effectiveness to determine if control efforts are successfully pushing $R_t$ below the critical threshold of $1$.", "problem": "A community is experiencing an HIV epidemic. The basic reproduction number $R_0$ is defined as the expected number of secondary infections generated by a single typical infected individual in a fully susceptible population in the absence of any intervention. At time $t$, Antiretroviral Therapy (ART) coverage is such that a fraction $\\alpha$ of people living with Human Immunodeficiency Virus (HIV) are on ART. For those on ART, the net transmissibility (interpreted as the product of per-contact transmission probability and effective infectiousness over time) is multiplicatively reduced by a factor $\\theta$ relative to no ART. Assume homogeneous mixing, that ART assignment does not change contact rates or the duration of infectiousness except through the reduction in transmissibility encoded by $\\theta$, and that the type-specific reproduction number scales proportionally with transmissibility.\n\nUsing the law of total expectation applied to ART status, derive a closed-form expression for the time-varying reproduction number $R_t$ as a function of $\\alpha$, $\\theta$, and $R_0$. Then evaluate $R_t$ for $R_0 = 2.4$, $\\alpha = 0.65$, and $\\theta = 0.08$. Round your final numerical answer to $4$ significant figures. Express the answer as a pure number without any units.", "solution": "The problem asks for the derivation of the time-varying reproduction number, $R_t$, in a population where a fraction of HIV-infected individuals are receiving Antiretroviral Therapy (ART), and for its subsequent numerical evaluation. The derivation will be based on the law of total expectation, applied to the partitioning of the infected population by ART status.\n\nLet $R_0$ be the basic reproduction number, defined as the expected number of secondary infections from a single infected individual in a fully susceptible population with no interventions. At time $t$, a fraction $\\alpha$ of the infected population is on ART, and the remaining fraction, $1-\\alpha$, is not.\n\nThe problem states that for an individual on ART, their net transmissibility is reduced by a multiplicative factor $\\theta$. It is also assumed that the reproduction number for a specific group of individuals scales proportionally with their net transmissibility.\n\nLet us denote the reproduction number for an untreated individual as $R_{noART}$ and for a treated individual as $R_{ART}$.\nAn untreated individual, by definition, has the baseline transmissibility associated with $R_0$. Thus, we can set their contribution to the spread of the epidemic to be equivalent to the basic reproduction number:\n$$R_{noART} = R_0$$\nFor an individual on ART, the transmissibility is reduced by the factor $\\theta$. Due to the proportional scaling assumption, their reproduction number is also reduced by the same factor:\n$$R_{ART} = \\theta R_0$$\nThe time-varying reproduction number, $R_t$, represents the average number of secondary infections generated by a single infected individual chosen at random from the entire infected population at time $t$. The population is composed of two disjoint groups: those on ART and those not on ART. We can calculate the expected value $R_t$ using the law of total expectation, conditioning on the ART status of the individual.\n\nLet $N$ be the random variable for the number of secondary infections caused by a randomly selected infected person. Let $A$ be the event that this person is on ART. The problem gives the probability of this event as $P(A) = \\alpha$. The complementary event, $A^c$, that the person is not on ART, has probability $P(A^c) = 1 - \\alpha$.\n\nAccording to the law of total expectation, the expected value of $N$, which is $R_t$, is given by:\n$$R_t = E[N] = E[N|A] P(A) + E[N|A^c] P(A^c)$$\nThe conditional expectation $E[N|A]$ is the average number of secondary infections from a person on ART, which we have established as $R_{ART} = \\theta R_0$.\nThe conditional expectation $E[N|A^c]$ is the average number of secondary infections from a person not on ART, which is $R_{noART} = R_0$.\n\nSubstituting these quantities into the equation for $R_t$:\n$$R_t = (\\theta R_0) \\cdot \\alpha + (R_0) \\cdot (1-\\alpha)$$\nThis expression represents $R_t$ as the weighted average of the reproduction numbers for the two subpopulations, with the weights being the proportions of each subpopulation. We can now simplify this expression to obtain the requested closed form.\n$$R_t = \\alpha \\theta R_0 + R_0 - \\alpha R_0$$\nFactoring out the common term $R_0$:\n$$R_t = R_0 (1 - \\alpha + \\alpha \\theta)$$\nThis can be further rearranged to highlight the reduction from $R_0$:\n$$R_t = R_0 [1 - \\alpha(1 - \\theta)]$$\nThis is the closed-form expression for $R_t$ as a function of $R_0$, $\\alpha$, and $\\theta$. The term $\\alpha(1-\\theta)$ represents the fraction of transmission events averted by the ART program.\n\nNext, we evaluate this expression using the provided numerical values: $R_0 = 2.4$, $\\alpha = 0.65$, and $\\theta = 0.08$.\n\nSubstituting these values into the derived formula:\n$$R_t = 2.4 \\times [1 - 0.65 \\times (1 - 0.08)]$$\nFirst, calculate the term inside the parentheses:\n$$1 - 0.08 = 0.92$$\nThen, multiply by the ART coverage $\\alpha$:\n$$0.65 \\times 0.92 = 0.598$$\nNow, substitute this back into the main expression:\n$$R_t = 2.4 \\times (1 - 0.598)$$\n$$R_t = 2.4 \\times 0.402$$\nPerforming the final multiplication:\n$$R_t = 0.9648$$\nThe problem requires the final answer to be rounded to $4$ significant figures. The calculated value $0.9648$ already has exactly four significant figures.\n\nThis result, $R_t \\approx 0.965$, being less than $1$, indicates that under the specified conditions of ART coverage and efficacy, the epidemic is expected to decline in the community, as each infected individual, on average, gives rise to fewer than one new infection.", "answer": "$$\\boxed{0.9648}$$", "id": "4985285"}, {"introduction": "Public health programs operate with finite resources, making it essential to evaluate the efficiency of interventions. The Number Needed to Treat (NNT) is a powerful and intuitive metric used to compare the effort required for different health strategies to prevent a single adverse outcome. This problem [@problem_id:4985242] challenges you to calculate the NNT for Pre-Exposure Prophylaxis (PrEP), a key HIV prevention tool. By working from fundamental principles of risk and hazard rates, you will translate program data on efficacy and adherence into a tangible number that directly informs policy and resource allocation decisions.", "problem": "A public health department is planning a two-year pre-exposure prophylaxis (PrEP) program for human immunodeficiency virus (HIV) prevention among a defined at-risk cohort. Assume a constant hazard (incidence rate) model and no indirect (herd) effects, no risk compensation, and independence between PrEP use and underlying risk.\n\nYou are given the following empirically grounded inputs:\n- The baseline HIV incidence rate in the target population is $\\lambda_0 = 2.4$ per $100$ person-years (person-years (PY)).\n- The time horizon is $T = 2$ years.\n- The biological efficacy of oral PrEP at full adherence is $\\varepsilon = 0.75$ (that is, a $0.75$ proportional reduction in per-time infection hazard under full adherence).\n- The mean adherence in the program is $a = 0.60$ (dimensionless, with $a=1$ denoting full adherence).\n\nUsing only the fundamental definitions of cumulative incidence under a constant hazard, absolute risk reduction, and the definition of the Number Needed to Treat (NNT), do the following:\n\n1) Derive an expression for the absolute risk reduction over time horizon $T$ when PrEP reduces the per-time hazard multiplicatively by a factor $1-\\varepsilon a$. Then derive the corresponding exact expression for the Number Needed to Treat to avert one infection over $T$.\n\n2) Show how, under the low-risk approximation, your expression simplifies to a form that is proportional to the inverse of the product of the baseline cumulative incidence, biological efficacy, and adherence. Clearly state the small-risk condition under which this approximation is valid.\n\n3) Using the given numerical values, compute the NNT over the $2$-year horizon. Round your final NNT to three significant figures. The final answer should be a single real number (dimensionless).", "solution": "The problem is validated as scientifically grounded, well-posed, and objective. It presents a standard epidemiological modeling exercise with realistic parameters. All necessary information is provided, and the questions are unambiguous.\n\nThe solution proceeds in three parts as requested.\n\nThe fundamental relationship between a constant hazard rate, $\\lambda$, and the cumulative incidence (risk), $R$, over a time period $T$ is given by the survival function $S(T) = \\exp(-\\lambda T)$. The risk is the complement of survival, $R(T) = 1 - S(T) = 1 - \\exp(-\\lambda T)$.\n\nThe baseline HIV incidence rate in the unexposed population is $\\lambda_0$. The risk of infection over the time horizon $T$ in this group is:\n$$R_0 = 1 - \\exp(-\\lambda_0 T)$$\n\nThe problem states that PrEP reduces the per-time hazard multiplicatively. The effective efficacy is the product of biological efficacy, $\\varepsilon$, and adherence, $a$. The hazard reduction factor is thus $\\varepsilon a$. The new hazard rate for an individual on PrEP, $\\lambda_1$, is:\n$$\\lambda_1 = \\lambda_0 (1 - \\varepsilon a)$$\nConsequently, the risk of infection for an individual on PrEP over the time horizon $T$ is:\n$$R_1 = 1 - \\exp(-\\lambda_1 T) = 1 - \\exp(-\\lambda_0 (1 - \\varepsilon a) T)$$\n\n1) Derivation of Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT)\n\nThe Absolute Risk Reduction, $ARR$, is the difference in risk between the unexposed group and the exposed (PrEP) group.\n$$ARR = R_0 - R_1$$\nSubstituting the expressions for $R_0$ and $R_1$:\n$$ARR = \\left[1 - \\exp(-\\lambda_0 T)\\right] - \\left[1 - \\exp(-\\lambda_0 (1 - \\varepsilon a) T)\\right]$$\n$$ARR = \\exp(-\\lambda_0 (1 - \\varepsilon a) T) - \\exp(-\\lambda_0 T)$$\nThe Number Needed to Treat, $NNT$, is defined as the reciprocal of the $ARR$. It represents the average number of people who need to be treated to prevent one adverse outcome.\n$$NNT = \\frac{1}{ARR}$$\nSubstituting the expression for $ARR$, the exact expression for the $NNT$ is:\n$$NNT = \\frac{1}{\\exp(-\\lambda_0 (1 - \\varepsilon a) T) - \\exp(-\\lambda_0 T)}$$\n\n2) Low-Risk Approximation\n\nThe low-risk approximation is valid when the cumulative incidence over the time horizon is small. This corresponds to the condition where the argument of the exponential function is much less than $1$. The small-risk condition is therefore:\n$$\\lambda_0 T \\ll 1$$\nUnder this condition, we can use the first-order Taylor series expansion for the exponential function, $\\exp(-x) \\approx 1 - x$ for small $x$.\n\nApplying this approximation to the risk expressions:\n$$R_0 = 1 - \\exp(-\\lambda_0 T) \\approx 1 - (1 - \\lambda_0 T) = \\lambda_0 T$$\n$$R_1 = 1 - \\exp(-\\lambda_1 T) \\approx 1 - (1 - \\lambda_1 T) = \\lambda_1 T = \\lambda_0 (1 - \\varepsilon a) T$$\nThe approximate $ARR$ is then:\n$$ARR_{approx} \\approx R_{0,approx} - R_{1,approx} = \\lambda_0 T - \\lambda_0 (1 - \\varepsilon a) T$$\n$$ARR_{approx} \\approx \\lambda_0 T - \\lambda_0 T + \\lambda_0 T \\varepsilon a = \\lambda_0 T \\varepsilon a$$\nThe approximate $NNT$ is the reciprocal of the approximate $ARR$:\n$$NNT_{approx} \\approx \\frac{1}{\\lambda_0 T \\varepsilon a}$$\nThe baseline cumulative incidence, $R_0$, under the low-risk approximation is $R_{0,approx} = \\lambda_0 T$. Substituting this into the expression for $NNT_{approx}$:\n$$NNT_{approx} \\approx \\frac{1}{R_{0,approx} \\cdot \\varepsilon \\cdot a}$$\nThis demonstrates that under the low-risk condition, the $NNT$ is approximately equal to the inverse of the product of the approximated baseline cumulative incidence ($\\lambda_0 T$), the biological efficacy ($\\varepsilon$), and the mean adherence ($a$).\n\n3) Numerical Calculation of NNT\n\nFirst, we must express all parameters in consistent units. The baseline incidence rate is given as $\\lambda_0 = 2.4$ per $100$ person-years. This is converted to a rate per person-year:\n$$\\lambda_0 = \\frac{2.4}{100} \\, \\text{year}^{-1} = 0.024 \\, \\text{year}^{-1}$$\nThe other given values are:\n- Time horizon, $T = 2$ years\n- Biological efficacy, $\\varepsilon = 0.75$\n- Mean adherence, $a = 0.60$\n\nWe use the exact formula for $NNT$ derived in part 1:\n$$NNT = \\frac{1}{\\exp(-\\lambda_0 (1 - \\varepsilon a) T) - \\exp(-\\lambda_0 T)}$$\nFirst, we compute the exponents:\nThe product $\\varepsilon a$ is:\n$$\\varepsilon a = 0.75 \\times 0.60 = 0.45$$\nThe exponent for the PrEP group is:\n$$-\\lambda_0 (1 - \\varepsilon a) T = -0.024 \\times (1 - 0.45) \\times 2 = -0.024 \\times 0.55 \\times 2 = -0.0264$$\nThe exponent for the control group is:\n$$-\\lambda_0 T = -0.024 \\times 2 = -0.048$$\nNow, substitute these values into the $NNT$ equation:\n$$NNT = \\frac{1}{\\exp(-0.0264) - \\exp(-0.048)}$$\nWe calculate the values of the exponential functions:\n$$\\exp(-0.0264) \\approx 0.97394498$$\n$$\\exp(-0.048) \\approx 0.95313636$$\nThe $ARR$ is the difference:\n$$ARR \\approx 0.97394498 - 0.95313636 = 0.02080862$$\nFinally, we calculate the $NNT$:\n$$NNT = \\frac{1}{0.02080862} \\approx 48.0569$$\nRounding the result to three significant figures, we get:\n$$NNT \\approx 48.1$$\nThis means that approximately $48$ individuals from the target population must be treated with PrEP for $2$ years to avert one HIV infection.", "answer": "$$\\boxed{48.1}$$", "id": "4985242"}]}